Efficacy and safety of Atezolizumab plus Bevacizumab and Lenvatinib as first-line systemic therapies for hepatocellular carcinoma: A real-world study - Sangdao Boonkaya; Chidkamon Pattarawongpaiboon; Panarat Thaimai; Prooksa Ananchuensook; Supachaya Sriphoosanaphan; Suebpong Tanasanvimon; Nattaya Teeyapun; Nussara Pakvisal; Nipaporn Siripon; Sombat Treeprasertsuk; Piyawat Komolmit; Kessarin Thanapirom (PLoS ONE, 2025)